S100A4 (also known as pEL98/mts1/p9Ka/18A2/42A/ calvasculin/FSP1/CAPL), a member of S100-related calcium-binding proteins, has been implicated to play a role in metastasis. In the present study, we examined the eect of antisense S100A4 RNA on metastatic potential of Lewis lung carcinoma (LLC) cells. High-metastatic A11 cells were transfected with the expression vector containing S100A4 cDNA in an inverted (antisense) orientation under the transcriptional control of the mouse metallothionein promoter. Treatment of a stably transfected clone (AS10 cells) with Zn 2+ resulted in the suppression of the experimental metastatic ability, which was accompanied with the expression of antisense S100A4 RNA and the suppression of the S100A4 expression at both the mRNA and the protein levels. To further con®rm the eect of antisense S100A4 RNA, we established several clones after retroviral transduction with an antisense S100A4 construct. Notably, reduced metastatic potential was also evident in these clones. In the antisense S100A4 RNA-expressing cells, cell motility and in vitro invasiveness were found to be suppressed.
Introduction S100A4 (also known as pEL98/mts1/p9Ka/18A2/42A/ calvasculin/FSP1/CAPL) belongs to the S100 subfamily of Ca 2+ -binding proteins. The S100A4 gene encodes an acidic 101 amino acid protein containing two EFhand motifs. The mouse S100A4 gene is located on chromosome 3 and the human gene on 1q21, both as a cluster with calcyclin (CACY/S100A6) and several other S100-related protein genes (SchaÈ fer et al., 1995) . The S100A4 gene was independently cloned from various sources based on dierent interests, and the gene product has been implicated to play important roles in many biological phenomena such as cell immortalization (Goto et al., 1988) , cell growth (Jackson-Grusby et al., 1987) , dierentiation of mammary epithelial stem cells to myoepithelial-like cells (Barraclough et al., 1987) , and ®brogenesis (Strutz et al., 1995) . In addition, recent studies have suggested the involvement of the gene product in the regulation of metastasis. S100A4 has been reported to be speci®cally expressed in metastatic tumor cells (Ebralidze et al., 1989) , and be able to induce metastatic phenotype in a benign rat mammary epithelial cell line (Davies et al., 1993) and in B16 melanoma cells (Parker et al., 1994) .
Biological function(s) of the S100A4 gene product is not fully understood yet. However, recent eorts to identify proteins which interacts with the S100A4 gene product have revealed non-muscle tropomyosins (Takenaga et al., 1994d) , non-muscle myosin (Kriajevska et al., 1994; Ford and Zain, 1995) and several unidenti®ed cellular proteins (Gibbs et al., 1994) as the eector proteins. Immuno¯uorescent staining of the cells using the speci®c antibodies has also demonstrated the co-localization of the gene product with actin micro®laments (Takenaga et al., 1994b,d; Kriajevska et al., 1994) . These results strongly implicate S100A4 in cytoskeletal dynamics and/or cell motility. Supporting this, embryonic trophoblast cells, lymphoid cells and macrophages, all of which are highly motile, are found to express a relatively high amount of S100A4 (Jackson-Grusby et al., 1987; Ford and Zain, 1995; Ebralidze et al., 1989; Grigorian et al., 1993; Takenaga et al., 1994b,c) . Furthermore, we and others have recently demonstrated the enhanced cell motility in S100A4 cDNA-transfected tumor cells (Takenaga et al., 1994a; Ford et al., 1995) .
We have previously reported that the expression level of S100A4 is correlated with the invasive abilities of various clones established from Lewis lung carcinoma (LLC) (Takenaga et al., 1994a) . In the present study, we examined whether expression of the antisense S100A4 aects the metastatic ability of highmetastatic LLC cells. The results show that the expression of antisense S100A4 RNA suppressed the metastatic capability of high-metastatic cells with concomitant suppressions of the motile and invasive abilities.
Results
Induction of antisense S100A4 RNA in A11 cells transfected with the plasmid pMTA4as
In order to evaluate the role of S100A4 in the acquisition of metastatic phenotype of LLC cells, the eect of antisense S100A4 expression was examined. For this purpose, high-metastatic A11 cells were transfected with the plasmid pMTA4as in which the expression of the inserted sequence is driven by the metallothionein promoter. After the selection of stable transfectants with G418, each of the transfectants was treated with 100 mM Zn 2+ for 24 h and examined for the expression of the S100A4 protein by Western blot analysis. One of the transfectants, designated as AS10, was used for the subsequent experiments. V5 cells which is a clone derived from A11 cells transfected with the vector alone were used as a control. Figure 1 shows the results of RT ± PCR analysis of the expression of antisense S100A4 RNA. Untreated A11 and V5 cells did not express the antisense RNA, but AS10 cells expressed a small amount of the RNA (Figure 1a ). Upon treatment with 100 mM Zn 2+ , the expression of the antisense RNA was signi®cantly induced in AS10 cells, but not in A11 and V5 cells (Figure 1a) . The induction was apparent as early as 12 h after treatment with Zn 2+ and declined thereafter (Figure 1b) .
The expression level of the S100A4 mRNA was examined by Northern blot analysis. The amount of the S100A4 mRNA was decreased in AS10 cells, but not in V5 cells, at the concentrations of Zn 2+ above 75 mM (Figure 2a ). The suppression was nearly maximal 24 h after the treatment and decreased thereafter (Figure 2b ). An additional band above the signal of S100A4 mRNA was observed on the blot after treatment with Zn
2+
, but the nature of the band is presently unknown. We also examined the expressions of calcyclin, another S100-related calcium-binding protein, nm23, matrix metallo-proteinase 9 (MMP9) and GAPDH mRNAs and found that the expressions of these mRNAs in AS10 cells remained unchanged after the Zn 2+ treatment (data not shown). Figure 3 shows the expression of the S100A4 protein analysed by Western blot analysis. Upon treatment with 100 mM Zn 2+ , the amount of the protein was slightly, but signi®cantly, reduced in AS10 cells, but not in V5 cells; in this case, the suppression of the protein synthesis became obvious as early as 24 h and was observed even 48 h after the treatment. RT ± PCR analysis of the expression of antisense S100A4 RNA in pMTA4as-transfected A11 cells. Total RNA prepared from A11, V5 and AS10 cells cultured with 100 mM Zn 2+ for 24 h (a) or for various times (b) were ®rst transcribed into cDNA using oligo d(T) 12 ± 18 as the RT primer and Moloney murine leukemia virus reverse transcriptase. The resulting cDNAs were used for the ampli®cation of the antisense S100A4 mRNA using the 5' and 3' primers and Ampli Taq DNA polymerase (Perkin Elmer). Aliquots of the RT ± PCR products were fractionated by electrophoresis in 1% agarose gels and visualized on a transilluminator after staining with ethidium bromide. For negative controls, RT ± PCR was performed without reverse transcriptase. Molecular size markers (DNA/HindIII fragments, 100 bp DNA ladder) were used to determine the size of the RT ± PCR products. The arrow indicates the position of the RT ± PCR product Northern blot analysis of the expression of S100A4 mRNA in pMTA4as-transfected A11 cells. Total RNA from V5 and AS10 cells cultured with various concentrations of Zn 2+ for 24 h (a) or with 100 mM Zn 2+ for various times (b) were electrophoresed on 1% agarose gels containing formaldehyde, transferred onto nylon ®lters, and hybridized with a 32 P-labeled S100A4 probe. Ethidium bromide staining of the agarose gels is shown at the bottom of the ®gure. The arrow indicates the position of the S100A4 mRNA Suppression of metastasis by antisense S100A4 RNA K Takenaga et al
Eects of antisense S100A4 RNA expression on metastatic potential of A11 cells transfected with pMTA4as
The metastatic abilities of A11, V5 and AS10 cells cultured for 24 h in the presence or absence of 100 mM Zn 2+ were examined by injecting the cells into the tail vein of the syngeneic mice. No change in the metastatic ability was observed in both A11 and V5 cells upon treatment with Zn 2+ (Table 1 ). In contrast, although the metastatic ability of AS10 cells was lower than that of A11 or V5 cells, Zn
-treated AS10 cells showed signi®cantly reduced metastatic ability compared with untreated cells (Table 1) .
Eects of antisense S100A4 RNA expression on motile and invasive abilities of A11 cells transfected with pMTA4as
The motile abilities of V5 and AS10 cells treated with Zn 2+ were evaluated. The cells were treated with 100 mM Zn 2+ for 24 h and then subjected to the motility assay for 12 h in the presence of 100 mM Zn
. As shown in Figure 4a , the motile ability of AS10 cells was slightly, but signi®cantly, suppressed by Zn 2+ , while those of A11 and V5 cells were unaected. Next, the in vitro invasive abilities of V5 and AS10 cells treated with 100 mM Zn 
Metastatic potential of A11 cells expressing antisense S100A4 RNA constitutively
We next tried to isolate several clones that constitutively express antisense S100A4 RNA. For this experiment, A11 cells were retrovirally transduced with LXSN or LA4asSN, and several clones, LV-or LA-clones, respectively, were established after the selection with G418. Western blot analysis revealed that LA-clones expressed a lower amount of the S100A4 protein than LV-clones and A11 cells (Figure 5a ). Northern blot Treatment time (hr) Figure 3 Western blot analysis of the expression of the S100A4 protein in pMTA4as-transfected A11 cells. V5 and AS10 cells were cultured with 100 mM Zn 2+ for various times. Cell extracts (20 mg of total protein) were electrophresed on 15% acrylamide gels under reducing conditions and the resolved proteins were transferred to nitrocellulose membrane. The S100A4 protein was detected using polyclonal anti-S100A4 antibodies and an ECL Western blotting detection kit. Only the region of interest is shown. The arrow indicates the position of the S100A4 protein Figure 4 Cell motility, invasiveness and adhesiveness of pMTA4as-transfected A11 cells. (a) Cell motility assay. A11, V5 and AS10 cells were cultured in the presence or absence of 100 mM Zn 2+ for 24 h and then subjected to the motility assay for 12 h. (b) Invasion assay. V5 and AS10 cells were cultured in the presence or absence of 100 mM Zn 2+ for 24 h and subjected to the invasion assay. (c) Spreading assay. A11, V5 and AS10 cells were cultured in the presence or absence of 100 mM Zn 2+ for 24 h and then subjected to the spreading assay. The values shown are the mean+s.d. Statistical analysis was performed by Student's t test. NS; not signi®cant analysis con®rmed the lower expression of S100A4 mRNA in LA-clones (data not shown). The metastatic potential of LV-and LA-clones was then evaluated. The results showed that the metastatic abilities of LA-clones were lower than those of LV-clones and A11 cells ( Table  2 ). The sizes of the metastatic foci formed by LA-clones were not dierent from those formed by LV-clones. In addition, examination of the histological sections of the metastases formed by LV-and LA-clones showed no signi®cant dierence in the in®ltration of lymphocytes and neutrophils (data not shown). These results may exclude the possibility that the reduction in metastasis formation by LA-clones is due to the decreased in vivo growth rate of the cells or the immunological modu lation. We also examined the motile and invasive abilities of LV-and LA-clone cells and found that both abilities were reduced in LA-clones compared with LV-clones (Figure 5b and c) .
Discussion
In order to ascertain whether S100A4 plays a role in metastatic capability of LLC cells, we transfected an antisense S100A4 construct whose expression is driven by the metallothionein promoter into high-metastatic A11 cells and established AS10 cells. Upon treatment with Zn 2+ , the induction of antisense S100A4 RNA and the concomitant reduction of S100A4 expression were observed in AS10 cells. This was speci®c for S100A4, since there was no alteration in the expression -treated AS10 cells. The results showed that the ability was signi®cantly suppressed compared to that of untreated cells, whereas that of V5 or A11 cells was not.
To further con®rm the eect of antisense S100A4 RNA on the metastatic phenotype of A11 cells, we isolated several clones, which constitutively expressed antisense S100A4 RNA, after retroviral transduction with the antisense S100A4 construct. Notably, the reduction of metastatic ability was also observed in these clones. We examined the histology and the size of the lung metastases formed by the control and the antisense RNA-expressing cells and found that there were no dierences in the size and the degree of immune cell in®ltration. These results excluded the possibility that the reduced metastatic ability was due to the reduced growth rate and the increased immunogenicity of the antisense RNA-expressing cells. Thus, in both inducible and constitutive systems, the expression of the antisense S100A4 RNA resulted in the inhibition of the metastatic capability of A11 cells. Grigorian et al. (1993) also observed a reduction in metastasis by transfecting CSML100 cells with an antisense S100A4 construct. Therefore, S100A4 probably plays a critical role in the acquisition of the metastatic phenotype of LLC cells and some other tumor cells as well.
The S100A4 protein has been shown to physically interact with various cytoskeletal components (Takenaga et al., 1994d; Kriajevska et al., 1994; Ford and Zain, 1994) . Enforced expression of the S100A4 protein in tumor cells results in enhancement of motility (Takenaga et al., 1994a; Ford and Zain, 1995) . S100A4 is also expressed in normal cells and tissues which exhibit highly motile ability (JacksonGrusby et al., 1987; Ebralidze et al., 1989; Ford and Zain, 1995; Grigorian et al., 1993; Takenaga et al., 1994b) . Furthermore, the expression of S100A4 was induced during the dierentiation of promyelocytic leukemia HL60 cells, coinciding with the expression of motile phenotype (Takenaga et al., 1994c) . Collectively, these results implicate a role of S100A4 in cell motility. In AS10 cells, the reduction of motility was apparent upon treatment with Zn 2+ . However, there remained the possibilities that the suppression of motility was merely due to the general cytotoxicity of Zn 2+ and that Zn 2+ treatment changed the adhesivity of AS10 cells which may in¯uence motility. It was also possible that the expressions of other gene products that regulate cell motility are altered by the expression of antisense S100A4 RNA. These genes include nm23 (Kantor et al., 1993) and GAPDH (Epner et al., 1993) ; the expressions of the former and the S100A4 gene are reported to be coregulated (Lakshmi et al., 1993) . To exclude these possibilities, we examined the ability of the cells to adhere to and spread on Matrigel and the expressions of the nm23 and GAPDH genes. However, no change in the adhesivity and the expressions of these genes was evident. The reduction of motile ability was also detected in several clones that constitutively expressed antisense S100A4 RNA, further strengthening the involvement of S100A4 in motility.
The reduction of in vitro invasiveness was obvious in the antisense S100A4 RNA-expressing A11 cells. Ford and Zain (1995) have recently reported that expression of S100A4 increases motility but not invasion of a nonmetastatic mammary adenocarcinoma cell. They argued that, besides S100A4, type IV collagenase activities may be necessary for the tumor cells to invade. Since A11 cells are highly metastatic, sucient type IV collagenase activities may already be present. In addition, there was no dierence in MMP9 expression between untreated and Zn 2+ -treated AS10 cells. Therefore, it is possible that the reduced cell motility may be mainly responsible for the suppression of invasiveness of A11 cells.
We have previously shown that there is a close correlation between the amount of the S100A4 protein and the extents of motile and invasive abilities in various LLC clones (Takenaga et al., 1994a) . The present data showed that even a slight suppression of the S100A4 expression as observed in Zn
2+
-treated AS10 cells resulted in the suppression of motility as well as invasiveness of A11 cells. These results imply that the changes in the expression of the S100A4 protein may sensitively aect the extents of the phenotypes in this tumor model.
Establishment of metastases requires multiple properties of tumor cells, in addition to those needed for motility and invasiveness, such as induction of platelet aggregation, resistance to immune responses, growth potential in target organs and resistance to programmed cell death (Liotta, 1988; Liotta and Stetler-Stevenson, 1991; Aznavoorian et al., 1992; Fidler and Hart, 1982; Glinsky and Glinsky, 1996) . These properties undoubtedly dier in each tumor and clone. Therefore, although the present results collectively suggest that S100A4 plays an important role in the acquisition of metastatic phenotype, the expression of S100A4 alone may not be sucient for conferring high metastatic potential on LLC cells. Nevertheless, further studies on the biological role of the S100A4 protein and the mechanism(s) by which the expression of S100A4 is regulated might give us the clues to suppress metastasis.
Materials and methods

Cells and cell culture
Cloned high-metastatic A11 cells derived from Lewis lung carcinoma (Takenaga et al., 1994) were cultured in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum, 100 mg/ ml of streptomycin and 100 units/ml of penicillin. They were grown in a humidi®ed atmosphere of 5% CO 2 in air.
Construction of antisense S100A4 expression vector and introduction into cells
The coding sequence of S100A4 cDNA (Goto et al., 1988) was excised from pGEM-3Z (Promega Biotec, Madison, WI) using PstI and KpnI after the methylation of the internal EcoRI site with EcoRI methylase (Takara Shuzo Co, Kyoto). The fragments were treated with T4 DNA polymerase and ligated to EcoRI linkers. After digestion with EcoRI the fragment was inserted into the EcoRI site of p75/15 poly(A) expression vector (a gift from Dr T Tokuhisa, Chiba University) or LXSN retrovirus vector (a gift from Dr AD Miller, Fred Hutchinson Cancer Research Center) in an inverted orientation to form a plasmid pMTA4as or LA4asSN, respectively. In the plasmid pMTA4as, the expression of the inserted sequence is driven by the mouse metallothionein promoter. The orientation of the inserted cDNA was veri®ed by restriction enzyme analysis.
Transfection of the plasmid and selection A11 cells were transfected with the plasmid pMTA4as using a Lipofectin method. Stable transfectants were then selected by exposure to 800 mg/ml of G418 (Life Technologies Inc, Gaithersburg, MD), and screened for S100A4 protein expression.
Generation of retroviruses and infection
The plasmid LA4asSN was transfected into c 2 packaging cells by a Lipofectin method. After selection with G418 (400 mg/ml), the cell-free culture supernatants containing retroviruses were saved. A11 cells were infected with the retroviruses in the presence of 8 mg/ml of polybrene (Aldrich Chemical Company, Inc, Milwaukee, WIS) and then exposed to 800 mg/ml of G418 to select for clones that expressed a low level of the S100A4 protein.
RNA extraction and Northern blotting
Total RNA was extracted with guanidinium thiocyanate (Sambrook et al., 1989) . Ten mg of total RNA were electrophoresed on 1% agarose gel containing formaldehyde (Sambrook et al., 1989) and transferred to nylon ®lters. Blots were hybridized with 32 P-labeled S100A4 (Takenaga et al., 1994) , calcyclin (5B10, a generous gift of Dr DT Denhardt), nm23, MMP9 (a gift of Dr H Tanaka) or GAPDH cDNA which was prepared by the random primer method (Sambrook et al., 1989) . Filters were ®nally washed at 508C in 30 mM NaCl, 3 mM sodium citrate and 0.1% sodium dodecyl sulfate.
Reverse transcription-polymerase chain reaction analysis (RT ± PCR)
The expression of antisense S100A4 mRNA was analysed by RT ± PCR. The position of the 5' primer is from 44 nt to 65 nt (5'-CAT GTG CGA AGA AGC CAG AGT A-3'), and the 3' primer sequence is from 405 nt to 384 nt (5'-CAC CTT CCA CAA ATA CTC AGG C-3') with regard to the reverse composition of the S100A4 sequence; the GenBank entry name being PCBP. Target mRNA was ®rst transcribed into cDNA using oligo d(T) 12 ± 18 as the RT primer and Moloney murine leukemia virus reverse transcriptase. The resulting cDNAs were used for the ampli®cation of the antisense S100A4 mRNA using the 5' and 3' primers and Ampli Taq DNA polymerase (Perkin Elmer, Foster City, CA). The condition for the PCR was 948C for 1 min, 558C for 2 min and 728C for 3 min, and the cycle was repeated 30 times. The ampli®ed fragment was 362 bp long. Aliquots of the RT ± PCR products were fractionated by electrophoresis in 1% agarose gels and visualized on a transilluminator after staining with ethidium bromide. For negative controls, RT ± PCR was performed without reverse transcriptase. Molecular size markers (l DNA/HindIII fragments, 100 bp DNA ladder; Life Technologies Inc) were used to determine the size of the RT ± PCR products.
SDS-polyacrylamide gel electrophoresis and Western blotting
Cells were washed three times with cold Dulbecco's phosphate-buered saline (DPBS). They were detached from the culture dishes by short exposure to 2 mM EDTA in DPBS and pelleted by centrifugation. They were then lyzed with a cold extraction buer consisting of 1% (v/v) Triton X-100, 150 mM NaCl, 50 mM Tris-HCl, pH 7.5, 1 mM EGTA and 1 mM PMSF for 10 min on ice. The cell lysate was centrifuged at 10 000 g for 10 min and the supernatant was used for subsequent analyses. SDS-polyacrylamide gel electrophoresis was performed under reducing conditions as described previously (Laemmli, 1970) using 15% polyacrylamide gels. Protein concentration was determined by the method of Bradford (1976) using bovine serum albumin as a standard. The resolved proteins were electrophoretically transferred to nitrocellulose membrane. The S100A4 protein was detected using anti-S100A4 antibodies (Takenaga et al., 1994) and an ECL Western blotting detection kit (Amersham International).
Cell adhesion assay
Wells of a 96-well plastic tissue culture plate were coated with 5 mg/ml of Matrigel (Collaborative Research Co.) overnight at 48C and then post-coated with 1% heat-denatured BSA for 1 h at room temperature to minimize background cell attachment and spreading. The wells were extensively washed with DPBS before use. The cells to be tested were suspended in serum-free DMEM and then placed in the coated wells at 5610 3 cells/well. After 45 min incubation at 378C, the cells were ®xed with 3% formaldehyde/3% glutaraldehyde and the percentage of spread cells was determined as described previously (Yamada et al., 1990) .
Cell motility assay
Cell motility was measured by phagokinetic track assay as described previously (Takenaga et al., 1994) . Brie¯y, cover slips were coated with 10 mg/ml of bovine serum albumin overnight at 48C and then coated with colloidal gold particles. Cells were seeded onto these cover slips at a density of 2000 cells per cover slip in 2 ml of the growth medium and cultured for 12 or 24 h in the presence or absence of 100 mM ZnSO 4 . The cells were ®xed with 3% formaldehyde and then coverslips were mounted. The areas where cells had moved were digitized and measured by using an image analysis program (NIH Image). Cell motility was evaluated by measuring more than 50 areas free of the gold particles.
In vitro invasion assay
Invasive ability was assayed as described previously (Takenaga et al., 1994) . Brie¯y, polycarbonate ®lters, 8 mm pore size (Coaster, Cambridge, MA), coated with 30 mg/®lter of Matrigel were placed in the blind well Boyden chambers. Cells were collected by a brief treatment with 2 mM EDTA in DPBS, resuspended in DMEM containing 0.1% bovine serum albumin, and then placed in the upper compartment of the chamber at a concentration of 2610 5 cells/200 ml. NIH3T3-conditioned media were used as chemoattractants in the lower compartment of the chamber. After incubation for 5 h at 378C, the ®lters were removed and the cells on the upper surface of the ®lter were removed by wiping with a cotton swab. The cells were ®xed with 3% formaldehyde and stained with MayGruÈ enwald-Giemsa. Cells from various areas (at least 10 areas) of the lower surface was counted.
Metastasis assay
Cells were collected by a short exposure to 2 mM EDTA in DPBS, centrifuged, and resuspended in Hank's balanced salt solution (HBSS). Experimental metastatic ability was measured by injecting 1610 5 cells/0.2 ml HBSS/mouse into the tail vein of age-matched male C57BL/6 mice (Nippon SLC, Hamamatsu). Seventeen days after the injection, mice were killed, and their lungs were removed. The lungs were rinsed in water and ®xed in Bouin's solution, and parietal metastatic nodules were counted under a dissecting microscope.
Histological examination
Lung metastases were ®xed with 10% formalin and embedded in paran. The 4 ± 5 mm thick sections cut from the paran blocks were stained with hematoxylineosin.
